Tibet AIM Pharm. Inc. (SHE:002826)
China flag China · Delayed Price · Currency is CNY
17.81
-0.52 (-2.84%)
May 21, 2026, 3:04 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Drug Sales
635.62M568.64M---
Drug Sales Growth
11.78%----
Drug Promotion Services
-1.10M78.60M---
Others
1.75M4.65M141.53M194.63M97.10M
Others Growth
-62.26%-96.72%-27.28%100.45%28.52%
Cardiovascular Medicines
--189.69M336.27M332.31M
Cardiovascular Medicines Growth
---43.59%1.19%31.12%
Diabetes
--335.82M325.84M190.07M
Diabetes Growth
--3.06%71.43%27.21%
Gynecology
----105.99M
Gynecology Growth
-----14.67%
Total
636.27M651.88M667.04M856.73M725.46M
Total Growth
-2.39%-2.27%-22.14%18.10%20.38%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
North China
137.45M124.42M134.74M183.28M139.94M
North China Growth
10.47%-7.66%-26.48%30.97%58.45%
East China
120.54M143.78M158.90M235.20M202.51M
East China Growth
-16.16%-9.52%-32.44%16.15%27.51%
Northwest
63.40M52.89M51.84M65.84M73.01M
Northwest Growth
19.88%2.02%-21.26%-9.82%37.30%
Southwest
294.46M263.23M224.00M216.93M158.05M
Southwest Growth
11.86%17.52%3.26%37.26%10.01%
Northeast
20.41M67.56M97.55M155.47M151.95M
Northeast Growth
-69.79%-30.75%-37.25%2.32%-4.21%
Total
636.27M651.88M667.04M856.73M725.46M
Total Growth
-2.39%-2.27%-22.14%18.10%20.38%
Source: S&P Global Market Intelligence.